These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats. Jover B; Stuit L; Mimran A J Hypertens; 2004 Feb; 22(2):383-8. PubMed ID: 15076198 [TBL] [Abstract][Full Text] [Related]
46. Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy. Davis BJ; Johnston CI; Burrell LM; Burns WC; Kubota E; Cao Z; Cooper ME; Allen TJ Diabetologia; 2003 Jul; 46(7):961-71. PubMed ID: 12838387 [TBL] [Abstract][Full Text] [Related]
47. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure. Xu J; Carretero OA; Liu YH; Yang F; Shesely EG; Oja-Tebbe N; Yang XP J Card Fail; 2004 Feb; 10(1):83-9. PubMed ID: 14966779 [TBL] [Abstract][Full Text] [Related]
48. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction. Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026 [TBL] [Abstract][Full Text] [Related]
49. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Nawarskas J; Rajan V; Frishman WH Heart Dis; 2001; 3(6):378-85. PubMed ID: 11975822 [TBL] [Abstract][Full Text] [Related]
50. Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: insights from experimental heart failure. Chen HH; Cataliotti A; Burnett JC Curr Hypertens Rep; 2001 Dec; 3 Suppl 2():S15-21. PubMed ID: 11716801 [TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor. Azizi M; Massien C; Michaud A; Corvol P Hypertension; 2000 Jun; 35(6):1226-31. PubMed ID: 10856268 [TBL] [Abstract][Full Text] [Related]
52. Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Ferrario CM; Averill DB; Brosnihan KB; Chappell MC; Iskandar SS; Dean RH; Diz DI Kidney Int; 2002 Oct; 62(4):1349-57. PubMed ID: 12234305 [TBL] [Abstract][Full Text] [Related]
53. Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics. Varagic J; Susic D; Slama M; Frohlich ED J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):167-74. PubMed ID: 12808490 [TBL] [Abstract][Full Text] [Related]
54. Vasopeptidase inhibition in a canine model of exercise-induced left ventricular dysfunction. Holzgrefe HH; Arthur SR; Powell JR Clin Exp Pharmacol Physiol; 2002 Aug; 29(8):696-703. PubMed ID: 12100002 [TBL] [Abstract][Full Text] [Related]
55. Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Bäcklund T; Palojoki E; Saraste A; Grönholm T; Eriksson A; Lakkisto P; Vuolteenaho O; Nieminen MS; Voipio-Pulkki LM; Laine M; Tikkanen I Cardiovasc Res; 2003 Mar; 57(3):727-37. PubMed ID: 12618234 [TBL] [Abstract][Full Text] [Related]
56. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats. Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672 [TBL] [Abstract][Full Text] [Related]
57. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats. Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359 [TBL] [Abstract][Full Text] [Related]
58. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. Sulpizio AC; Pullen MA; Edwards RM; Brooks DP J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834 [TBL] [Abstract][Full Text] [Related]
59. Short-term effects of quinapril and nifedipine on early renal changes in streptozotocin-induced diabetes in rats. Petitjean P; Vloemans M; Barthelmebs M; Stephan D; Grima M; Jund A; Imbs JL Fundam Clin Pharmacol; 1994; 8(4):356-65. PubMed ID: 7851841 [TBL] [Abstract][Full Text] [Related]
60. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]